OSTX Cash From Financing

Annual CFF

$2.87 M
-$779.10 K-21.33%

December 31, 2023


Summary


Performance

OSTX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOSTXcash flowmetrics:

Quarterly CFF

$5.15 M
+$4.27 M+487.74%

September 30, 2024


Summary


Performance

OSTX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOSTXcash flowmetrics:

TTM CFF

$7.62 M
+$4.30 M+129.80%

September 30, 2024


Summary


Performance

OSTX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOSTXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

OSTX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.3%+487.7%+129.8%
3 y3 years-5.8%+487.7%+129.8%
5 y5 years-5.8%+487.7%+129.8%

OSTX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.3%at lowat high+880.4%at high+1147.7%
5 y5-year-21.3%at lowat high+880.4%at high+1147.7%
alltimeall time-21.3%at lowat high+880.4%at high+1147.7%

OS Therapies Incorporated Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$5.15 M(+487.7%)
$7.62 M(+129.8%)
Jun 2024
-
$875.90 K(+24.6%)
$3.32 M(+11.8%)
Mar 2024
-
$703.00 K(-21.4%)
$2.97 M(+3.2%)
Dec 2023
$2.87 M
$894.10 K(+6.0%)
$2.87 M(+45.2%)
Sep 2023
-
$843.40 K(+60.6%)
$1.98 M(+74.2%)
DateAnnualQuarterlyTTM
Jun 2023
-
$525.10 K(-14.0%)
$1.14 M(+86.0%)
Mar 2023
-
$610.80 K(-34.0%)
$610.80 K(-34.0%)
Dec 2022
$3.65 M(+19.7%)
-
-
Mar 2022
-
$925.00 K
$925.00 K
Dec 2021
$3.05 M
-
-

FAQ

  • What is OS Therapies Incorporated annual cash flow from financing activities?
  • What is the all time high annual CFF for OS Therapies Incorporated?
  • What is OS Therapies Incorporated annual CFF year-on-year change?
  • What is OS Therapies Incorporated quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for OS Therapies Incorporated?
  • What is OS Therapies Incorporated quarterly CFF year-on-year change?
  • What is OS Therapies Incorporated TTM cash flow from financing activities?
  • What is the all time high TTM CFF for OS Therapies Incorporated?
  • What is OS Therapies Incorporated TTM CFF year-on-year change?

What is OS Therapies Incorporated annual cash flow from financing activities?

The current annual CFF of OSTX is $2.87 M

What is the all time high annual CFF for OS Therapies Incorporated?

OS Therapies Incorporated all-time high annual cash flow from financing activities is $3.65 M

What is OS Therapies Incorporated annual CFF year-on-year change?

Over the past year, OSTX annual cash flow from financing activities has changed by -$779.10 K (-21.33%)

What is OS Therapies Incorporated quarterly cash flow from financing activities?

The current quarterly CFF of OSTX is $5.15 M

What is the all time high quarterly CFF for OS Therapies Incorporated?

OS Therapies Incorporated all-time high quarterly cash flow from financing activities is $5.15 M

What is OS Therapies Incorporated quarterly CFF year-on-year change?

Over the past year, OSTX quarterly cash flow from financing activities has changed by +$4.27 M (+487.74%)

What is OS Therapies Incorporated TTM cash flow from financing activities?

The current TTM CFF of OSTX is $7.62 M

What is the all time high TTM CFF for OS Therapies Incorporated?

OS Therapies Incorporated all-time high TTM cash flow from financing activities is $7.62 M

What is OS Therapies Incorporated TTM CFF year-on-year change?

Over the past year, OSTX TTM cash flow from financing activities has changed by +$4.30 M (+129.80%)